Anti-infective Drugs Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 35 | Published : January 2018 | SKU CODE : 2765 | Format :

Infectious diseases are disorders caused by several pathogenic organisms such as bacteria, viruses, fungi or parasites. These diseases can be transmitted or spread from one person to another through direct contact or indirect contact. Anti-infective drugs are used to treat or prevent these infectious diseases by inhibiting the spread of an infectious agent (static) or by killing the infectious agent (cidal).

The top five companies covered are Gilead Sciences Inc., Merck & Co., GlaxosmithKline Plc., Bristol-Myers Squibb Company and Johnson & Johnson. Gilead was the largest competitor in the anti-infective drugs market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The global anti-infective drugs market was valued at around $117 billion in 2017. North America was the largest region in the anti-infective drugs market in 2017, accounting for 30% market share. The USA was the largest country in the market in 2017, accounting for nearly 25% market share.

Companies in the anti-infective drugs market are working towards constant innovation to provide more effective drugs and also to sustain in the competition of the market. The FDA approved 22 new drugs in 2016. Among them, drugs for infectious diseases held the largest share with 40% (9) approvals. Recently approved antibiotic drugs include Descovy from Gilead Lifesciences, Zepatier from Merck & Co. and others.

The anti infective drugs market is segmented into Antiviral Drugs, Antibacterial Drugs/Antibiotic Drugs, Antifungal Drugs and Antiparasitic Drugs. Antiviral Drugs are used to treat viral infections. These drugs are classified into anti-herpes virus agents, anti-influenza agents, antiretroviral agents, anti-hepatitis agents and other antiviral agents. Antibacterial Drugs/Antibiotic Drugs are used to treat or prevent the bacterial infections. They may kill or inhibit the growth of bacteria. Antifungal Drugs are used to treat fungal infections. These drugs can be classified into azole derivatives including fluconazole, itraconazole, ketoconazole, polyene antibiotics including amphotericin B, nystatin, allylamine drugs including terbinafine, nafitifine and echinocandin drugs including caspofungin, micafungin, anidulafungin. Antiparasitic Drugs are used to treat infections caused by parasites. These can be classified into antiprotozoal, antimalarial, antihelminthic and ectoparasiticide drugs.

Next-gen Biologics- The Way Forward

The Telemedicine Technology Market Will More Than Double by 2022

Minor Orthopedic Replacement Implants Global Market Exceeds $1.5 Billion

Minor orthopedic implant market to be worth $2.2 billion by 2021, analysts say

Organs-on-Chips to Revolutionize the Drug Development Industry

Russia’s Musculoskeletal Drugs Market Is Catching Up With The Rest Of Europe

The Fastest Growing Regions for Dermatological Drug Sales Are the Middle East and South America

Growth of Middle Class Is Causing Heart Drugs Market In Asia Pacific To Accelerate, Says TBRC

Blood Glucose Test Strips Global Market Report 2018

View Report

Veterinary Services Global Market Report 2018

View Report

Podiatry Services Global Market Strategies and Opportunities to 2021

View Report

Minor Orthopedic Implants Replacement Global Market Opportunities And Strategies To 2021

View Report

Biologics Global Market Opportunities And Strategies To 2021

View Report

Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021

View Report

Blood Glucose Test Strips Global Market Opportunities And Strategies To 2021

View Report

Veterinary Serices Global Market Opportunities And Strategies To 2021

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)